| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATAD5 | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-18 |
| mRNA | CCNI2 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-17 |
| mRNA | GOLGA7 | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-17 |
| mRNA | ELOVL4 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-16 |
| mRNA | RGPD2 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-15 |
| mRNA | PITPNM2 | CTRPv2 | pan-cancer | AAC | 0.3 | 8e-15 |
| mRNA | KCNK12 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-14 |
| mRNA | PIDD1 | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-14 |
| mRNA | OR10R2 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-14 |
| mRNA | RGPD4 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-13 |
